PSTB100 Study in Healthy Adult Subjects

Clinical trial NCT07702279 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07702279
Sponsor: Prospect Therapeutics (Nanjing) Limited
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2026-07-28
Primary completion: 2027-06-12
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.